local_hospital

Praxis Dr. Peters

Address
Berner Heerweg 157, 22159 Hamburg, Germany

Bacterial Infections and Mycoses (C01)

The department is evaluating novel therapies for acute vaginal infections, aiming to reduce symptoms and restore normal flora.

  • Bacterial Vaginosis
  • Vulvovaginal Candidiasis
  • Mixed BV/VVC infections

Findings from these studies will help inform treatment guidelines at Praxis Dr. Peters.

Female Urogenital Diseases and Pregnancy Complications (C13)

Research focuses on relieving menstrual pain, improving contraceptive options, and preventing unintended pregnancies.

  • Primary Dysmenorrhea
  • Levonorgestrel Vaginal Delivery System
  • Pregnancy Prevention

The outcomes aim to enhance quality of life for women treated at Praxis Dr. Peters.

Virus Diseases (C02)

A vaccine candidate is being tested to protect women of child‑bearing age from Cytomegalovirus infection.

  • CMV Prevention
  • Vaccine Immunogenicity
  • Safety and Reactogenicity

Successful results could reduce congenital infections in the community served by the clinic.

Reproductive and Urinary Physiological Phenomena (G08)

Studies examine estrogen‑based vaginal rings to treat vaginal atrophy and assess changes in epithelial health and pH.

  • Estriol Vaginal Ring
  • Vaginal Epithelium Cytology
  • Vaginal pH Modulation

These investigations support improved management of menopausal symptoms for patients of Praxis Dr. Peters.

Site Overview

assignment
5
connected trials
corporate_fare
4
sponsors
science
5
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
5
Total trials linked
Active
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
0
Sponsors (total)
4
Active sponsors
0

Sponsor Network

Top 10 by active trials.

No sponsors linked to active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 2 161 other sites in Germany

description
Trial volume
5
Outperforms 72% of sites
public
Therapeutic diversity
4areas
Outperforms 86% of sites
groups
Sponsor diversity
4sponsors
Outperforms 71% of sites

Therapeutic Area Benchmark — Germany

Select a therapeutic area to compare against other sites in Germany.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Germany

Market Share

Country: Germany

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Praxis Dr. Peters

lock Showing 1 of 5 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
A multicentre, single arm trial on contraceptive efficacy, safety and tolerability of LVDS (Levonorgestrel Vaginal Delivery System) during 13 cycles.Chemo Research S.L.Phase IIINot RecruitingJul 2023Aug 2025

IMP list

lock Showing 1 of 5 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Levonorgestrel2Unknown2023-07-122023-07-12

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.